EMA And Drug Makers Debate PRIME, Adaptive Pathways, Alzheimer's - And More
This article was originally published in SRA
Executive Summary
Scrip Regulatory Affairs editor Maureen Kenny was at the European Medicines Agency in London on Nov. 19 reporting from a meeting where regulators and drug makers explored the challenges they face and the opportunities ahead.